First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications

Biology of the Cell

Volumn 105, Issue 7, 2013, Pages 289-303

  Miller, Isabella V ^a   Raposo, Graca ^b,c   Welsch, Ulrich ^d   Prazeres da Costa, Olivia ^a   Thiel, Uwe ^a   Lebar, Maria ^e   Maurer, Martina ^a   Bender, Hans Ulrich ^a   von Luettichau, Irene ^a   Richter, Günther H S ^a   Burdach, Stefan ^a   Grunewald, Thomas G P ^b,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

^d UNIVERSITY OF MUNICH   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarker; Ewing's sarcoma; Exosomes; Extracellular vesicles; Microarray

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPI PROTEIN; MESSENGER RNA; NUCLEAR RECEPTOR DAX 1; RIBONUCLEASE; RNA; STEAP1 PROTEIN; TRANSCRIPTION FACTOR NKX2.2; UNCLASSIFIED DRUG;

ARTICLE; BONE CANCER; CANCER CELL CULTURE; CELL VACUOLE; ELECTRON MICROSCOPY; EWING SARCOMA; EXOSOME; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; MICROARRAY ANALYSIS; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOFT TISSUE; ULTRACENTRIFUGATION;

BIOMARKER; EWING'S SARCOMA; EXOSOMES; EXTRACELLULAR VESICLES; MICROARRAY;

ANTIGENS, CD63; ANTIGENS, CD81; BIOLOGICAL MARKERS; CELL LINE, TUMOR; EXOSOMES; HUMANS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEIN C-FLI-1; RNA-BINDING PROTEIN EWS; SARCOMA, EWING; SOFT TISSUE NEOPLASMS;

EID: 84879879298     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1111/boc.201200086     Document Type: Article

References (63)

1. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A. and Rak, J. (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624
2. Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Depoortere, F., Coomans, C., Vermeiren, E., et al. (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685
3. Bobrie, A., Colombo, M., Raposo, G. and Thery, C. (2011). Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12, 1659-1668
4. Bryant, R.J., Pawlowski, T., Catto, J.W., Marsden, G., Vessella, R.L., Rhees, B., Kuslich, C., Visakorpi, T. and Hamdy, F.C. (2012). Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 106, 768-774
5. Burdach, S., Plehm, S., Unland, R., Dirksen, U., Borkhardt, A., Staege, M.S., Muller-Tidow, C. and Richter, G.H. (2009). Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2. Cell Cycle 8, 1991-1996
6. Chang, C.J. and Hung, M.C. (2012). The role of EZH2 in tumour progression. Br J Cancer 106, 243-247
7. Chaput, N. and Thery, C. (2011). Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33, 419-440
8. Cheung, I.Y., Feng, Y., Danis, K., Shukla, N., Meyers, P., Ladanyi, M. and Cheung, N.K. (2007). Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin Cancer Res 13, 6978-6983
9. Cotterill, S.J., Ahrens, S., Paulussen, M., Jurgens, H.F., Voute, P.A., Gadner, H. and Craft, A.W. (2000). Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18, 3108-3114
10. Delattre, O., Zucman, J., Melot, T., Garau, X.S., Zucker, J.M., Lenoir, G.M., Ambros, P.F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994). The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. New Engl J Med 331, 294-299
11. Diehl, J.A. (2002). Cycling to cancer with cyclin D1. Cancer Biol Ther 1, 226-231
12. Duijvesz, D., Luider, T., Bangma, C.H. and Jenster, G. (2011). Exosomes as biomarker treasure chests for prostate cancer. Eur Urol 59, 823-831
13. Eldh, M., Lotvall, J., Malmhall, C. and Ekstrom, K. (2012). Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol 50, 278-286
14. Escola, J.M., Kleijmeer, M.J., Stoorvogel, W., Griffith, J.M., Yoshie, O. and Geuze, H.J. (1998). Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273, 20121-20127
15. Garcia-Aragoncillo, E., Carrillo, J., Lalli, E., Agra, N., Gomez-Lopez, G., Pestana, A. and Alonso, J. (2008). DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene 27, 6034-6043
16. Ge, X., Yamamoto, S., Tsutsumi, S., Midorikawa, Y., Ihara, S., Wang, S.M. and Aburatani, H. (2005). Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86, 127-141
17. Grunewald, T.G., Bach, H., Cossarizza, A. and Matsumoto, I. (2012a). The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. Biol Cell 104, 641-657
18. Grunewald, T.G., Diebold, I., Esposito, I., Plehm, S., Hauer, K., Thiel, U., da Silva-Buttkus, P., Neff, F., Unland, R., Muller-Tidow, C., et al. (2012b). STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol Cancer Res 10, 52-65
19. Grunewald, T.G., Ranft, A., Esposito, I., da Silva-Buttkus, P., Aichler, M., Baumhoer, D., Schaefer, K.L., Ottaviano, L., Poremba, C., Jundt, G., et al. (2012c). High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients. Ann Oncol 23, 2185-2190
20. Gu, J., Qian, H., Shen, L., Zhang, X., Zhu, W., Huang, L., Yan, Y., Mao, F., Zhao, C., Shi, Y., et al. (2012). Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta/Smad pathway. PloS ONE 7, e52465
21. Hood, J.L., San, R.S. and Wickline, S.A. (2011). Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801
22. James, K., Eisenhauer, E., Christian, M., Terenziani, M., Vena, D., Muldal, A. and Therasse, P. (1999). Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91, 523-528
23. Keller, S., Konig, A.K., Marme, F., Runz, S., Wolterink, S., Koensgen, D., Mustea, A., Sehouli, J. and Altevogt, P. (2009). Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 278, 73-81
24. Keller, S., Ridinger, J., Rupp, A.K., Janssen, J.W. and Altevogt, P. (2011). Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9, 86
25. Kinsey, M., Smith, R. and Lessnick, S.L. (2006). NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 4, 851-859
26. Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabro, L., Spada, M., Perdicchio, M., Marino, M.L., Federici, C., Iessi, E., et al. (2009). High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PloS ONE 4, e5219
27. Luga, V., Zhang, L., Viloria-Petit, A.M., Ogunjimi, A.A., Inanlou, M.R., Chiu, E., Buchanan, M., Hosein, A.N., Basik, M. and Wrana, J.L. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542-1556
28. May, W.A., Gishizky, M.L., Lessnick, S.L., Lunsford, L.B., Lewis, B.C., Delattre, O., Zucman, J., Thomas, G. and Denny, C.T. (1993). Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U.S.A. 90, 5752-5756
29. Michelet, X., Djeddi, A. and Legouis, R. (2010). Developmental and cellular functions of the ESCRT machinery in pluricellular organisms. Biol Cell 102, 191-202
30. Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B.E., Jaenisch, R., Lander, E.S. and Meissner, A. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55
31. Minogue, S. and Waugh, M.G. (2012). Lipid rafts, microdomain heterogeneity and inter-organelle contacts: impacts on membrane preparation for proteomic studies. Biol. Cell 104, 618-627
32. Nakamura, N. (2010). Emerging new roles of GM130, a cis-Golgi matrix protein, in higher order cell functions. J Pharmacol Sci 112, 255-264
33. Nazarenko, I., Rana, S., Baumann, A., McAlear, J., Hellwig, A., Trendelenburg, M., Lochnit, G., Preissner, K.T. and Zoller, M. (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70, 1668-1678
34. Noerholm, M., Balaj, L., Limperg, T., Salehi, A., Zhu, L.D., Hochberg, F.H., Breakefield, X.O., Carter, B.S. and Skog, J. (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 12, 22
35. Pant, S., Hilton, H. and Burczynski, M.E. (2012). The multifaceted exosome: biogenesis, role in normal and aberrant cellular function and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 83, 1484-1494
36. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18, 883-891
37. Postel-Vinay, S., Véron, A.S., Tirode, F., Pierron, G., Reynaud, S., Kovar, H., Oberlin, O., Lapouble, E., Ballet, S., Lucchesi, C., et al. (2012). Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44, 323-327
38. Rabinowits, G., Gercel-Taylor, C., Day, J.M., Taylor, D.D. and Kloecker, G.H. (2009). Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10, 42-46
39. Rana, S. and Zoller, M. (2011). Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem Soc Trans 39, 559-562
40. Raposo, G., Nijman, H.W., Stoorvogel, W., Liejendekker, R., Harding, C.V., Melief, C.J. and Geuze, H.J. (1996). B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183, 1161-1172
41. Reddi, K.K. and Holland, J.F. (1976). Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U.S.A. 73, 2308-2310
42. Revet, I., Huizenga, G., Koster, J., Volckmann, R., van Sluis, P., Versteeg, R. and Geerts, D. (2010). MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3 and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. Cancer Lett 289, 195-207
43. Richter, G.H., Plehm, S., Fasan, A., Rossler, S., Unland, R., Bennani-Baiti, I.M., Hotfilder, M., Lowel, D., von Luettichau, I., Mossbrugger, I., et al. (2009). EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci U.S.A. 106, 5324-5329
44. Roth, R.B., Hevezi, P., Lee, J., Willhite, D., Lechner, S.M., Foster, A.C. and Zlotnik, A. (2006). Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 7, 67-80
45. Savola, S., Klami, A., Myllykangas, S., Manara, C., Scotlandi, K., Picci, P., Knuutila, S. and Vakkila, J. (2011). High expression of complement component 5 (C5) at tumor site associates with superior survival in ewing's sarcoma family of tumour patients. ISRN Oncol 2011, 168712
46. Schaefer, K.L., Eisenacher, M., Braun, Y., Brachwitz, K., Wai, D.H., Dirksen, U., Lanvers-Kaminsky, C., Juergens, H., Herrero, D., Stegmaier, S., et al. (2008). Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer 44, 699-709
47. Schmiedel, B.J., Hutter, C., Hesse, M. and Staege, M.S. (2011). Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumor cells. Mol Biol Rep 38, 4619-4628
48. Scotlandi, K., Remondini, D., Castellani, G., Manara, M.C., Nardi, F., Cantiani, L., Francesconi, M., Mercuri, M., Caccuri, A.M., Serra, M., et al. (2009). Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol 27, 2209-2216
49. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T., Jr., Carter, B.S., Krichevsky, A.M. and Breakefield, X.O. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10, 1470-1476
50. Smith, R., Owen, L.A., Trem, D.J., Wong, J.S., Whangbo, J.S., Golub, T.R. and Lessnick, S.L. (2006). Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9, 405-416
51. Staege, M.S., Hutter, C., Neumann, I., Foja, S., Hattenhorst, U.E., Hansen, G., Afar, D. and Burdach, S.E. (2004). DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64, 8213-8221
52. Svensson, K.J., Kucharzewska, P., Christianson, H.C., Skold, S., Lofstedt, T., Johansson, M.C., Morgelin, M., Bengzon, J., Ruf, W. and Belting, M. (2011). Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U.S.A. 108, 13147-13152
53. Thery, C., Amigorena, S., Raposo, G. and Clayton, A. (2006).Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. Chapter 3, 30:3.22.1-3.22.29, John Wiley & Sons, Hoboken.
54. Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P. and Delattre, O. (2007). Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11, 421-429
55. Toomey, E.C., Schiffman, J.D. and Lessnick, S.L. (2010). Recent advances in the molecular pathogenesis of Ewing's sarcoma. Oncogene 29, 4504-4516
56. Tsui, N.B., Ng, E.K. and Lo, Y.M. (2002). Stability of endogenous and added RNA in blood specimens, serum and plasma. Clin Chem 48, 1647-1653
57. Umezu, T., Ohyashiki, K., Kuroda, M. and Ohyashiki, J.H. (2012). Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene, doi:10.1038/onc.2012.295
58. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J. and Lotvall, J.O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654-659
59. Vermeulen, J., Ballet, S., Oberlin, O., Peter, M., Pierron, G., Longavenne, E., Laurence, V., Kanold, J., Chastagner, P., Lejars, O., et al. (2006). Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour. Br J Cancer 95, 1326-1333
60. von Levetzow, C., Jiang, X., Gwye, Y., von Levetzow, G., Hung, L., Cooper, A., Hsu, J.H. and Lawlor, E.R. (2011). Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS ONE 6, e19305
61. Williams, D.B. (2006). Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci 119, 615-623
62. Willier, S., Butt, E., Richter, G.H., Burdach, S. and Grunewald, T.G. (2011). Defining the role of TRIP6 in cell physiology and cancer. Biol Cell 103, 573-591
63. Yoshida, A., Sekine, S., Tsuta, K., Fukayama, M., Furuta, K. and Tsuda, H. (2012). NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36, 993-999